Common use
Dexlansoprazole is a next-generation proton pump inhibitor (PPI) used to effectively treat gastroesophageal reflux disease (GERD), heal erosive esophagitis, and maintain healing of the esophageal lining. It works by significantly reducing the amount of hydrochloric acid produced by the parietal cells in the stomach lining, providing long-lasting relief from heartburn, acid regurgitation, and related digestive discomfort. Unlike many other PPIs, dexlansoprazole features a unique dual delayed-release formulation that delivers the active ingredient in two separate doses, offering extended acid suppression throughout the day and night. When you buy dexlansoprazole online, you receive a clinically proven acid reflux treatment that is also marketed under the brand name Dexilant. This dexlansoprazole generic offers the same therapeutic benefits as the original branded product at a more affordable price, making it an excellent choice for patients requiring long-term GERD management.

Dosage and direction
Take dexlansoprazole once daily, preferably at least 30 minutes before a meal, or as prescribed by your physician. The typical dose for healing erosive esophagitis is 60 mg once daily for up to 8 weeks, while the maintenance dose for healed erosive esophagitis and symptomatic non-erosive GERD is typically 30 mg once daily. Swallow the capsule whole with a full glass of water — do not crush, chew, or open the capsule. For patients who have difficulty swallowing capsules, the contents may be carefully sprinkled on a tablespoon of applesauce, swallowed immediately without chewing, and followed with water. Do not adjust your dose or discontinue treatment without consulting your doctor, as premature cessation may lead to symptom recurrence.

Precautions
Before starting dexlansoprazole, inform your doctor if you have liver disease (particularly moderate to severe hepatic impairment), low magnesium levels (hypomagnesemia), or a history of stomach or intestinal conditions including gastric polyps. Long-term use of proton pump inhibitors, including dexlansoprazole, may increase the risk of osteoporosis-related bone fractures (particularly of the hip, wrist, or spine), chronic kidney disease, Clostridium difficile-associated diarrhea, and low vitamin B12 levels. Regular monitoring of magnesium levels and bone density may be recommended for patients on prolonged PPI therapy. Use dexlansoprazole only for as long as medically necessary, and discuss periodic reassessment of treatment with your healthcare provider.

Contraindications
Do not use dexlansoprazole if you are allergic to dexlansoprazole, lansoprazole, or any other proton pump inhibitor. This medication is contraindicated in individuals with a documented history of hypersensitivity reactions to PPIs, including anaphylaxis, severe skin reactions, or interstitial nephritis. Patients taking rilpivirine-containing HIV medications should not use dexlansoprazole, as PPIs significantly reduce rilpivirine absorption and efficacy.

Possible side effect
Common side effects of dexlansoprazole include headache, diarrhea, abdominal pain, nausea, flatulence, and upper respiratory tract infections. Most of these effects are mild and transient. Serious side effects, while rare, can include acute or chronic kidney problems (interstitial nephritis), severe allergic reactions (anaphylaxis, angioedema), Clostridium difficile colitis, and hypomagnesemia, which may manifest as muscle cramps, tremors, seizures, or irregular heartbeat. Prolonged use may also increase the risk of fundic gland polyps. Seek immediate medical attention if you experience severe diarrhea with fever, unusual muscle weakness, or signs of an allergic reaction.

Drug interaction
Dexlansoprazole may interact with several important medications. It can affect the absorption and efficacy of drugs that require an acidic gastric pH, including certain antifungals (ketoconazole, itraconazole), ampicillin esters, iron salts, and erlotinib. Dexlansoprazole may increase the blood-thinning effect of warfarin, requiring more frequent INR monitoring. It should not be co-administered with rilpivirine-containing HIV medications or with atazanavir. Concomitant use with methotrexate, particularly at high doses, may increase methotrexate levels and toxicity. Always inform your healthcare provider about all current medications, including prescription drugs, over-the-counter medicines, and dietary supplements, to avoid potentially harmful interactions.

Missed dose
If you miss a dose of dexlansoprazole, take it as soon as you remember, unless it is already close to the time of your next scheduled dose. In that case, skip the missed dose and continue with your regular once-daily dosing schedule. Do not take two doses at once to compensate for a missed dose. Consistent daily dosing is important for maintaining effective acid suppression and symptom control.

Overdose
Overdose symptoms may include confusion, severe drowsiness, dizziness, rapid or irregular heartbeat, nausea, and dry mouth. In case of suspected overdose, seek immediate medical attention by contacting your healthcare provider, local poison control center, or emergency services. Treatment is supportive and symptomatic, as there is no specific antidote for dexlansoprazole.

Storage
Store dexlansoprazole at controlled room temperature between 20–25°C (68–77°F), away from excessive moisture, heat, and direct sunlight. Keep the medication in its original container with the cap tightly closed. Do not use past the expiration date. Store out of the reach of children and pets.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.